Here is the latest stock price and chart of GLENMARK PHARMA. For more details, see the GLENMARK PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
One Stock Crorepati: Today is Your LAST Chance to Grab this Opportunity
Live BSE Quotes | Jul 4, 2022 03:31:00 PM | ||
---|---|---|---|
Price (Rs)388.00 | Open (Rs) 396.70 | High (Rs) 397.00 | Low (Rs) 384.10 |
% Change-1.52 | Volume 20,403 | Value (Rs) 7,916,364 | 52-Week H/L 690.60 / 348.90 |
Live NSE Quotes | Jul 4, 2022 3:29:56 PM | ||
---|---|---|---|
Price (Rs)387.05 | Open (Rs) 394.10 | High (Rs) 397.40 | Low (Rs) 384.00 |
% Change-1.79 | Volume 516,166 | Value (Rs) 200,432,419 | 52-Week H/L 690.95 / 348.50 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.52% | 1 Month -1.18% | 3 Months -15.74% | 1 Year -41.39% | 5 Years (CAGR)* -9.59% | 10 Years (CAGR)* 0.23% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 35.21 | P/E Ratio (x) 11.02 | Market Cap (Rs m) 109,481.26 | P/BV (x) 1.23 | Dividend Yield (%) 0.64 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
GLENMARK PHARMA last traded price was down 1.5% to Rs 388.0 on the BSE. On the NSE, GLENMARK PHARMA last traded price was down 1.8% to Rs 387.1. The total volume of shares traded was 0.5 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.0%. And the benchmark S&P BSE SENSEX was at 53,234.8 (up 0.6%).
Over the last 30 days, the GLENMARK PHARMA share price is down 5.3%. And over the last one year, GLENMARK PHARMA share price is down 40.6%.
The current market capitalisation of GLENMARK PHARMA stands at Rs 109,481.26 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2022, company promoters held 46.65% stake in GLENMARK PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of GLENMARK PHARMA.
What else is happening in the markets today? Dig in...
The last traded price of GLENMARK PHARMA was Rs 388.0 on the BSE, down 1.5% over the previous close. On the NSE, GLENMARK PHARMA last traded price was down 1.8% at Rs 387.1.
The current market capitalisation of GLENMARK PHARMA stands at Rs 109,481 m.
GLENMARK PHARMA had an EPS of Rs 35.2 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 6.1.
For the financial year 2021, GLENMARK PHARMA declared dividend amounting to Rs 2.5 per share. At the current price of Rs 388.0, this results in a dividend yield of 0.6%.
After opening the day on a choppy note, Indian share markets rallied as the session progressed and ended higher.
It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.
Here's why Divi's Lab's stock fell over 10% in two days.
For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?
More Views on NewsThis aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.
The good side of a market correction? Investors get consistent compounding stocks at a discount.
Why this may not be the best time to buy smallcaps.
These value stocks have the potential to deliver good returns in the long run. Watch out for them.
Global markets have become volatile, sending chills through the crude oil market.
More